What is Cadence?
Based in New York, Cadence operates as a sophisticated health-tech platform designed to bridge the gap between clinical environments and patient homes. By aggregating and interpreting real-time patient vitals, the company enables health systems to deliver personalized, responsive care that was previously unattainable. This technological framework is positioned to disrupt traditional disease management models, offering a scalable solution for large-scale health systems aiming to improve patient outcomes while optimizing operational efficiency. The company's market position is bolstered by its ability to integrate seamlessly into existing healthcare workflows, providing actionable insights that drive clinical decision-making.
How much funding has Cadence raised?
Cadence has raised a total of $241.9M across 4 funding rounds:
Angel/Seed
$874K
Series A
$41M
Series B
$100M
Series C
$100M
Angel/Seed (2018): $874K, investors not publicly disclosed
Series A (2021): $41M led by General Catalyst and Thrive Capital
Series B (2021): $100M supported by Coatue, General Catalyst, and Thrive Capital
Series C (2026): $100M featuring General Catalyst, Memorial Hermann, B Capital Group, Coatue, Duke Health, Corewell Health Ventures, Spark Capital, and Thrive Capital
Key Investors in Cadence
General Catalyst
A venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, with deep expertise in healthcare and enterprise software.
Thrive Capital
A New York-based investment firm that specializes in internet and software-driven businesses, providing strategic guidance to high-growth companies.
Coatue
An employee-owned hedge fund sponsor that invests in both public and private equity, with a strong focus on technology and global market trends.
What's next for Cadence?
With the successful closure of its latest financing round, Cadence is well-positioned to accelerate its expansion into new clinical verticals and deepen its technological capabilities. The strategic backing from a consortium of venture capital firms and health system partners suggests a focus on scaling its platform to meet the increasing demand for remote patient monitoring and virtual care solutions. Moving forward, the company is expected to leverage this capital to enhance its machine learning algorithms, expand its footprint within major health systems, and solidify its status as a leader in the digital health transformation landscape.
See full Cadence company page
